The initial characterization of the TauPS19 mice has demonstrated that Tau-linked aggregates and related cellular deficits manifested as early as 3-month-old age and became prominent at 6-month-old age, although neuronal loss in hippocampus and cognitive decline were not evident at these ages [32]. The gene discussed is MAPT; the disease is Mental deterioration.